Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke
<strong>Aims:</strong> PCSK9 genetic variants that have large effects on low density lipoprotein cholesterol (LDL-C) and coronary heart disease (CHD) have prompted the development of therapeutic PCSK9-inhibition. However, there is limited evidence that PCSK9 variants are associated with...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Oxford University Press
2017
|